Sanofi SA
LSE:0O59
Sanofi SA
LSE:0O59
Price:
80.465
EUR
0.06%
Market Cap:
€100.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sanofi SA
LSE:0O59
|
FR |
|
E
|
Enzon Pharmaceuticals Inc
SWB:EZ1
|
US |
|
B
|
Black Sea Property AS
OSE:BSP
|
NO |
|
E
|
Eugene Investment & Securities Co Ltd
KRX:001200
|
KR |
|
T
|
Taihan Textile Co Ltd
KRX:001070
|
KR |
|
Z
|
Zhejiang Bangjie Holding Group Co Ltd
SZSE:002634
|
CN |
|
D&G Technology Holding Co Ltd
HKEX:1301
|
CN |
|
M
|
Maywood Acquisition Corp
NASDAQ:MAYA
|
US |
|
Isofol Medical AB (publ)
STO:ISOFOL
|
SE |
|
V
|
Voyant International Corp
OTC:VOYT
|
US |
|
Brother Industries Ltd
OTC:BRTHF
|
JP |
|
Z
|
Zhejiang Changhua Auto Parts Co Ltd
SSE:605018
|
CN |
|
Gentera SAB de CV
OTC:CMPRF
|
MX |
Multiples-Based Value
The
Multiples-Based Value for
Sanofi SA (0O59)
under the Base Case is
hidden
EUR.
Compared with the current market price of 80.465 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0O59 Multiples-Based Value
LOCKED
Multiples Across Competitors
0O59 Competitors Multiples
Sanofi SA Competitors
Sanofi SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
LSE:0O59
|
97.4B EUR | 2.1 | 12.5 | 10.5 | 10.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.4 | 16.8 | 23.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
